News

News Heading link

blue ribbon for prostate cancer awareness

Round 2 U2D2 Proposals have been funded!

Posted on October 31, 2023

The UICentre and the UI Cancer are continuing their collaboration to provide seed grants ($25K each) for promising new cancer therapeutic approaches. Today we announce our second round of awards, which are directed…

Inaugural U2D2 Proposals have been funded!

Posted on February 22, 2023

In Fall 2022, the University of Illinois Cancer Center (UICC) and UICentre joined forces to launch a new cancer drug discovery RFA entitled “U2D2”. Today we are announcing our first $25K awards: Identification…

Paul Carlier joins UIC as Director of UICentre and Professor of Pharmaceutical Sciences

Laura Hayes | Posted on August 18, 2022

Paul Carlier is the new director of UICentre, UIC's campus-wide drug discovery initiative that supports translational, "bench to bedside" scientific research. He also joins the Departments of Pharmaceutical Sciences & Chemistry as professor.

Sunshine Biopharma Expands Anti-Coronavirus Drug Development Program by Signing a Collaboration Agreement with The University of Arizona

Posted on February 25, 2022

Read Article (https://finance.yahoo.com/news/sunshine-biopharma-expands-anti-coronavirus-130000673.html)

Lab results show promise for future pancreatic cancer treatment

Posted on February 07, 2022

Read Article (https://today.uic.edu/lab-results-show-promise-for-future-pancreatic-cancer-treatment/)

Novel Compound Doubles Mean Survival in Pre-Clinical Study

Posted on January 24, 2022

Read Article (https://cancer.uillinois.edu/novel-compound-doubles-mean-survival-in-pre-clinical-study/)

Where Innovation Shines

Posted on June 22, 2021

Read Article (https://issuu.com/uicpharmacy/docs/p2101109_cop_pharmacist_sum_q3_5d/s/12620013)

Novel COVID-19 drug blocks viral replication

Posted on March 24, 2021

Read Article (https://today.uic.edu/novel-covid-19-drug-blocks-viral-replication)

New drug target for Ebola, Marburg viruses

Posted on February 08, 2021

Read Article (https://today.uic.edu/new-drug-target-for-ebola-marburg-viruses)

Phase 1 human trials suggest UIC-developed breast cancer drug is safe, effective

Posted on August 27, 2020

Read Article (https://today.uic.edu/phase-1-human-trials-suggest-uic-developed-breast-cancer-drug-is-safe-effective)

Your browser is unsupported

UICentre | UIC's Campus-wide Drug Discovery Enterprise

News

News Heading link

Round 2 U2D2 Proposals have been funded!

Inaugural U2D2 Proposals have been funded!

Paul Carlier joins UIC as Director of UICentre and Professor of Pharmaceutical Sciences

Sunshine Biopharma Expands Anti-Coronavirus Drug Development Program by Signing a Collaboration Agreement with The University of Arizona

Lab results show promise for future pancreatic cancer treatment

Novel Compound Doubles Mean Survival in Pre-Clinical Study

Where Innovation Shines

Novel COVID-19 drug blocks viral replication

New drug target for Ebola, Marburg viruses

Phase 1 human trials suggest UIC-developed breast cancer drug is safe, effective

Your browser is unsupported

News

News Heading link Copy link

News Heading link